All rights reserved Intervention effect and dose-dependent response of Tanreqing injection on airway inflammation in lipopolysaccharide-induced rats

Journal of Traditional Chinese Medicine

Volumn 33, Issue 4, 2013, Pages 505-512

  Dong, Shoujin ^a   Zhong, Yunqing ^b   Yang, Kun ^c   Xiong, Xiaoling ^d   Mao, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d Integrative Traditional and Western Medicine hospital of Sichuan Province   (China)

Author keywords

Airway inflammation; Dose response relationship, drug; Lipopolysaccharides; Pulmonary disease, chronic obstructive; Tanreqing injection

Indexed keywords

CHINESE DRUG; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TANREQING; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NEUTROPHIL COUNT; NONHUMAN; RAT; RESPIRATORY TRACT INFLAMMATION; ANIMAL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; NEUTROPHIL; RESPIRATORY TRACT DISEASES; SPRAGUE DAWLEY RAT; DRUG EFFECT; RESPIRATORY TRACT DISEASE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY TRACT DISEASES;

EID: 84882986770     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tetley T D. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(6):607-618.
2. Chung K F. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(6):619-625.
3. Barnes P J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56(4):515-548.
4. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158(4):1277-1285.
5. Barnes P J. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003;54(2):113-129.
6. O'Donnell R, Breen D, Wilson S, et al. Inflammatory cells in the airways in COPD. Thorax 2006; 61(5): 448-454.
7. Qaseem A, Wilt T J, Weinberger S E, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. ANN INTERN MED 2011; 155(3): 179-191.
8. Gan W Q, Man S F, Sin D D. Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med 2005;5(3):1-14.
9. Yue Y Y, Li Y C. Experimental study on protective effects of Salvia on airway in the chronic obstructive pulmonary disease rat model. Lin Chuang He Li Yong Yao 2011; 4(8C): 15-17.
10. Li X C, Yin Y. Effects of modified Yuebijiabanxia decoction on serum IL-8and TNF-αin COPD model rats. Wu Jing Yi Xue Yuan Xue Bao 2011;20(6):472-474.
11. Lee H, Lee D, Kim Y, et al. Lipopolysaccharide-induced lung inflammation is inhibited by Lonicera japonica. Mol Cell Toxicol 2011;7(1):87-93.
12. Liu Y B, Shen W G, Liu L L. Effects of Runfei Oral Liquid on expressions of TNF-α, ICAM-1protein and IL-8in bronchus of the rat with chronic bronchial inflammation. Zhong Guo Lao Nian Yi Xue Za Zhi 2007;27(1):8-11.
13. Ou X M, Feng Y L, Wen F Q, et al. Macrolides attenuate mucus hypersecretion in rat airway through inactivation of NF-kappaB. Respirology 2008;13(1):63-72.
14. Deng X L, Zhong X G, Zhang X J, et al. Protective effect of Tanreqing injection on immunological liver injury. Zhong Guo Zhong Yao Za Zhi 2011;36(5):636-638.
15. Shi X Y. Medical laboratory animal sciences. Xian: Shanxi Science and Technology Press, 1989:422.
16. Redl H, Bahrami S, Schlag G, et al. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993;187(3-5):330-345.
17. Matute-Bello G, Frevert C W, Martin T R. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295(3): L379-L399.
18. Luo X H, Wan D J, Niu X T, et al. The protective effect of ulinastatin on multiple organ dysfunction syndromes of sheep. Zhong Guo Lao Nian Duo Qi Guan Ji Bing Za Zhi 2011;10(5):431-434.
19. Bishop R E. Fundamentals of endotoxin structure and function. Contrib Microbiol 2005;12(1):1-27.
20. Wang X J, Quinn P J. Endotoxins: structure, function and recognition. Springer-Verlag: Springer Science Business Media, 2010:153-170.
21. Zhang H, Li L, Mao E Q. P38 and sepsis. Sheng Ming Ke Xue 2007;19(4):417-422.
22. Yanagihara K, Seki M, Cheng P W. Lipopolysaccharide induces mucus cell metaplasia in mouse lung. Am J Respir Crit Cell Mol Biol 2001;24(1):66-73.
23. Gorska K, Krenke R, Domagala-Kulawik J, et al. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study. J Physiol Pharmacol 2008; 59(Suppl 6):271-283.
24. Shimura S. Bronchoalveolar lavage in diagnosis of chronic obstructive pulmonary disease. Nihon Rinsho 1999; 57(9):2005-2011.
25. Sapey E, Ahmad A, Bayley D, et al. Imbalances between interleukin-1and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol 2009; 29(4): 508-516.
26. Chung K F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001;34(Suppl):50s-59s.
27. Chung K F. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005;4(6):619-625.
28. Di Stefano A, Capelli A, Donner C F. Role of interleukin-8in the pathogenesis and treatment of COPD. Chest 2004;126(3):676-678.
29. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997;112(2):505-510.
30. Watanabe K, Suematsu M, Iida M, et al. Effect of rat CINC/gro, a member of the interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol 1992;56(1):60-69.
31. Watanabe K, Koizumi F, Kurashige Y, et al. Rat CINC, a member of the interleukin-8family, is a neutrophil-specific chemoattractant in vivo. Exp Mol Pathol 1991; 55(1): 30-37.
32. Iida M, Watanabe K, Tsurufuji M, et al. Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats. Infect Immun 1992 Apr;60(4):1268-1272.
33. Keatings V M, Collins P D, Scott D M, et al. Differences in interleukin-8and tumor necrosis factor-αin induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153(2):530-534.
34. Tsoumakidou M, Tzanakis N, Siafakas N M. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003;97(8):863-871.
35. Arsalane K, Broeckaert F, Knoops B, et al. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med 2000; 161(5): 1624-1630.
36. Ulich T R, Waston L R, Yin S M, et al. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1, and TNF-induced inflammatory infiltrate. Am J Pathol 1991;138(6):1485-1496.
37. Liaudet L, Pacher P, Mabley J G, et al. Activation of poly (ADP-Ribose) polymerase-1is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002;165(3):372-377.
38. Li P T, Zhang N, Zhu X L, et al. Experimental study on effect of Tanreqing Injection on acute lung injury induced by endotoxin injection. Zhong Guo Yao Xue Za Zhi 2005;40(7):518-521.
39. Pan Y S, Zhang N, Zhu X L, et al. Correlative research on Tanreqing Injection intervening the pathological process of endotoxemia. Zhong Guo Zhong Yi Ji Chu Za Zhi 2005;11(7):508-510.